18F–Prostate-Specific Membrane Antigen 1007 and 18F-FCH PET/CT in Local Recurrence of Prostate CancerWitkowska-Patena, Ewa, MD; Giżewska, Agnieszka, PhD; Miśko, Jolanta, PhD; Dziuk, Mirosław, PhDClinical Nuclear Medicine: June 2019 - Volume 44 - Issue 6 - p e401–e403 doi: 10.1097/RLU.0000000000002556 Interesting Images Buy Abstract Author InformationAuthors Article MetricsMetrics 18F–prostate-specific membrane antigen (PSMA) 1007 is one of the most promising radiotracers for PET imaging of relapsing prostate cancer. Minimal urinary clearance seems to be its most valuable and outstanding feature. We present images of biochemically relapsed prostate cancer where 18F-PSMA-1007 PET/CT (performed to verify an ambiguous finding adjacent to the urinary bladder found in 18F-FCH PET/CT) proved superior to radiocholine and precisely visualized site of local recurrence. From the Affidea Mazovian PET/CT Centre, Warsaw, Poland. Received for publication January 2, 2019; revision accepted February 10, 2019. Conflicts of interest and sources of funding: none declared. Correspondence to: Ewa Witkowska-Patena, MD, Affidea Mazovian PET/CT Centre, 128 Szaserów St, 04-349, Warsaw, Poland. E-mail: firstname.lastname@example.org. Copyright © 2019 Wolters Kluwer Health, Inc. All rights reserved.